Company

Synaps Dx

Synaps Dx develops diagnostic tests for Alzheimer's disease and other forms of dementia.

About

Founded in 2016 and based in Rockville, US, Synaps Dx develops diagnostic tools for Alzheimer's disease. Its DISCERN™ test is described as an autopsy-validated, minimally invasive test to distinguish Alzheimer's from other dementias. In October 2021, it raised USD 10 mn in Series A funding to scale production and meet demand.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in